BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
hit the ground running. Extremely fast pace. Welcoming teams and a lot of support
Quelles sont les meilleures choses à propos de votre équipe?
young and very hard worker team members
Quelle est la meilleure partie de votre programme de rémunération?
annual pay salary and bonus
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
welcoming and sense of community. We are in this together
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Very open and transparent. Committed to make fair and agreed upon decisions.
Qu’est-ce qui vous rend le plus heureux au travail?
Compensation and knowing we can resolves problems together to get these therapies available
Other Employee Reviews for BlueRock Therapeutics
×